カテゴリ： GlobalData, ルクセンブルク, 企業調査

Eurofins Scientific SE (ERF)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Eurofins Scientific SE (ERF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C9951
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：92
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ルクセンブルク
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE (ERF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Eurofins Scientific to Acquire Testing Business from Exova 14
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 15
Eurofins Scientific Acquires Assets of Discovery and Development Solutions Business of Merck 16
Viracor-IBT Labs Completes Acquisition Of Lab Operations Of National Institute of Transplantation 17
Venture Financing 18
Diatherix Secures Additional US$0.53 Million In Venture Financing 18
Partnerships 19
GATC Biotech Enters into Agreement with University of Konstanz 19
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 20
Qiagen Enters into Agreement with GATC Biotech 21
Merger 22
Bactimm Farma And Proxy Labs Merge To Form Sinensis Life Sciences 22
Equity Offering 23
Eurofins Scientific Raises USD347.1 Million in Private Placement of Shares 23
Eurofins Scientific Raises USD333 Million in Private Placement of Shares 24
Debt Offering 25
Eurofins Scientific Raises USD464.7 Million in Public Offering of 3.25% Bonds 25
Eurofins Scientific Raises USD745.3 Million in Public Offering of 2.125% Bonds Due 2024 26
Eurofins Scientific Raises USD554 Million in Public Offering of 3.375% Bonds Due 2023 27
Eurofins Scientific Prices USD322 Million in Public Offering of 4.87% Bond Due 2023 28
Eurofins Scientific Raises USD579 Million in Public Offering of 2.25% Bond Due 2022 29
Eurofins Prices Public Offering Of Bonds Due 2018 For US$405.1 Million 30
Acquisition 31
Eurofins Acquires Covance from LabCorp 31
Eurofins Scientific to Acquire PHAST 33
Eurofins Scientific Acquires Selcia 34
Eurofins Pharma Services Acquires Majority Stake in Advinus Therapeutics 35
Eurofins Scientific to Acquire DiscoverX 37
Eurofins Scientific Acquires Amatsigroup from Ekkio Capital 38
Eurofins GSC Lux Acquires ANA Laboratories 39
Eurofins Scientific Acquires Alphora Research 40
Eurofins Scientific to Acquire GATC Biotech 41
Amatsigroup Acquires Disposable-Lab 42
Eurofins Scientific to Acquire Villapharma Research 43
Amatsigroup Acquires Q-Biologicals 44
Eurofins Scientific Acquires Sinensis Life Sciences 45
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 46
Eurofins Scientific Acquires QC Laboratories (QCL) 47
Amatsi Acquires Seps Pharma 48
Eurofins Scientific to Acquire SF Analytical Labs 49
Eurofins Genomics Acquires VBC-Biotech 50
Eurofins Scientific Completes Acquisition of Viracor-IBT Labs For USD255 Million 51
Eurofins Scientific Acquires IDmyk 52
Eurofins Scientific Acquires 81% Stake In Agrisearch Services 53
Eurofins Discovery Services Acquires Majority Stake In Cerep 54
Eurofins Scientific Acquires Aros Applied Biotech, Genomic Solutions Provider 55
Proxy Labs Acquires MicroSafe Laboratories From Millipore 56
Eurofins Scientific SE – Key Competitors 57
Eurofins Scientific SE – Key Employees 58
Eurofins Scientific SE – Locations And Subsidiaries 59
Head Office 59
Other Locations & Subsidiaries 59
Recent Developments 63
Financial Announcements 63
Oct 23, 2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020 – Revenues objective for 2020 now set at EUR 5bn 63
Jul 31, 2018: Eurofins delivers strong revenue, profitability and cash flow growth in H1 2018 65
Jun 26, 2018: Eurofins raises its revenues objectives for 2018 to EUR 3.8bn (4bn pro-forma), to 4.3bn for 2019 and to 4.7bn for 2020 71
Apr 24, 2018: Eurofins revenues grow +23% in Q1 2018 to EUR 839m 72
Mar 06, 2018: Eurofins exceeds its recently-upgraded 2017 objectives on a strong growth momentum and raises its objectives for 2018 73
Oct 24, 2017: After Strong NM 2017 Performance Eurofins Brings Forward by 1 Year, to 2019, Its EUR 4bn Annual Revenues Objective 80
Aug 30, 2017: Eurofins Reports Solid H1 2017 Results 81
Feb 28, 2017: Eurofins: Full Year 2016 Results 86
Product News 91
Oct 02, 2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan 91
Appendix 92
Methodology 92
About GlobalData 92
Contact Us 92
Disclaimer 92

List of Tables
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Eurofins Scientific to Acquire Testing Business from Exova 14
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 15
Eurofins Scientific Acquires Assets of Discovery and Development Solutions Business of Merck 16
Viracor-IBT Labs Completes Acquisition Of Lab Operations Of National Institute of Transplantation 17
Diatherix Secures Additional US$0.53 Million In Venture Financing 18
GATC Biotech Enters into Agreement with University of Konstanz 19
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 20
Qiagen Enters into Agreement with GATC Biotech 21
Bactimm Farma And Proxy Labs Merge To Form Sinensis Life Sciences 22
Eurofins Scientific Raises USD347.1 Million in Private Placement of Shares 23
Eurofins Scientific Raises USD333 Million in Private Placement of Shares 24
Eurofins Scientific Raises USD464.7 Million in Public Offering of 3.25% Bonds 25
Eurofins Scientific Raises USD745.3 Million in Public Offering of 2.125% Bonds Due 2024 26
Eurofins Scientific Raises USD554 Million in Public Offering of 3.375% Bonds Due 2023 27
Eurofins Scientific Prices USD322 Million in Public Offering of 4.87% Bond Due 2023 28
Eurofins Scientific Raises USD579 Million in Public Offering of 2.25% Bond Due 2022 29
Eurofins Prices Public Offering Of Bonds Due 2018 For US$405.1 Million 30
Eurofins Acquires Covance from LabCorp 31
Eurofins Scientific to Acquire PHAST 33
Eurofins Scientific Acquires Selcia 34
Eurofins Pharma Services Acquires Majority Stake in Advinus Therapeutics 35
Eurofins Scientific to Acquire DiscoverX 37
Eurofins Scientific Acquires Amatsigroup from Ekkio Capital 38
Eurofins GSC Lux Acquires ANA Laboratories 39
Eurofins Scientific Acquires Alphora Research 40
Eurofins Scientific to Acquire GATC Biotech 41
Amatsigroup Acquires Disposable-Lab 42
Eurofins Scientific to Acquire Villapharma Research 43
Amatsigroup Acquires Q-Biologicals 44
Eurofins Scientific Acquires Sinensis Life Sciences 45
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 46
Eurofins Scientific Acquires QC Laboratories (QCL) 47
Amatsi Acquires Seps Pharma 48
Eurofins Scientific to Acquire SF Analytical Labs 49
Eurofins Genomics Acquires VBC-Biotech 50
Eurofins Scientific Completes Acquisition of Viracor-IBT Labs For USD255 Million 51
Eurofins Scientific Acquires IDmyk 52
Eurofins Scientific Acquires 81% Stake In Agrisearch Services 53
Eurofins Discovery Services Acquires Majority Stake In Cerep 54
Eurofins Scientific Acquires Aros Applied Biotech, Genomic Solutions Provider 55
Proxy Labs Acquires MicroSafe Laboratories From Millipore 56
Eurofins Scientific SE, Key Competitors 57
Eurofins Scientific SE, Key Employees 58
Eurofins Scientific SE, Subsidiaries 59

List of Figures
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Eurofins Scientific SE (ERF)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Alafair Biosciences Inc：医療機器：M&Aディール及び事業提携情報
    Summary Alafair Biosciences Inc (Alafair Biosciences) is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound …
  • AMETEK Inc (AME)-医療機器分野：企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Shopper’s Stop Ltd.：戦略・SWOT・企業財務分析
    Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Asda Stores Ltd：戦略・SWOT・企業財務分析
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bangladesh Power Development Board-エネルギー分野：企業M&A・提携分析
    Summary Bangladesh Power Development Board (BPDB) is an integrated energy statutory board. It generates electricity through owned power plants and procures electricity from public and private generation companies. The board utilizes gas, coal, hydro, furnace oil, and diesel as fuel source for electr …
  • Uscom Ltd (UCM)：企業の製品パイプライン分析
    Summary Uscom Ltd (Uscom) is a medical device company which focuses on the development, design, manufacture and marketing of non-invasive cardiovascular and pulmonary monitoring technologies. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac output monitor) non-inv …
  • CorEnergy Infrastructure Trust Inc (CORR)：企業の財務・戦略的SWOT分析
    CorEnergy Infrastructure Trust Inc (CORR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Immuno-Biological Laboratories Co Ltd (4570)：製薬・医療：M&Aディール及び事業提携情報
    Summary Immuno-Biological Laboratories Co Ltd (IBL) is a pharmaceutical company that develops, manufactures and markets diagnostic products. The company provides business areas such as diagnostic and research reagents, customized services, global sales network, protein production business using tran …
  • Meggitt Plc (MGGT)：企業の財務・戦略的SWOT分析
    Meggitt Plc (MGGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • GN Store Nord AS (GN)：企業の財務・戦略的SWOT分析
    GN Store Nord AS (GN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Torm Plc (TRMD A)：石油・ガス：M&Aディール及び事業提携情報
    Summary Torm Plc (Torm) is a shipping company serving the oil and gas sector. It offers a range of transportation services through its affiliated companies. The company undertakes transportation of refined oil products such as gasoline, jet fuel, naphtha, gas oil and fuel oil through its product tan …
  • Premaitha Health Plc (NIPT)：企業の財務・戦略的SWOT分析
    Premaitha Health Plc (NIPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • OTE Group：企業の戦略・SWOT・財務情報
    OTE Group - Strategy, SWOT and Corporate Finance Report Summary OTE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Swift Biosciences Inc-製薬・医療分野：企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Coats Group plc：企業のM&A・事業提携・投資動向
    Coats Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coats Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Ecrins Therapeutics SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company offers products such as native and labeled tubulin, tubulin polymerization kit, monoclonal a …
  • NovoCure Ltd (NVCR)：製薬・医療：M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Spark New Zealand Ltd (SPK)：企業の財務・戦略的SWOT分析
    Spark New Zealand Ltd (SPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TWi Pharmaceuticals Inc (4180)-製薬・医療分野：企業M&A・提携分析
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a manufacturer of high barrier generics drugs. The company’s products include donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine …
  • British American Tobacco Plc (BATS)：企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆